Are too many Americans taking antidepressants?

Antidepressants are among the most commonly prescribed medications in the U.S., with 1 in 6 American adults taking them. Over half of these prescriptions are for a type of drug called selective serotonin reuptake inhibitors (SSRIs), which includes well-known medications like Prozac (fluoxetine). SSRIs were first approved in 1987, and several variations now exist. While these drugs can be effective for moderate to severe depression, they are typically not recommended for mild depression due to potential side effects that may outweigh benefits. Mild depression often responds better to non-medication treatments, such as therapy or lifestyle changes. However, the line between mild and severe depression is not always clear, leading to potential overprescription.

Most antidepressant prescriptions in the U.S. are written by primary care providers rather than psychiatrists. In 2026, an analysis found that primary care providers, including nurse practitioners and physician assistants, prescribe the majority of antidepressants. Primary care doctors often have less time to evaluate mental health concerns and fewer alternatives to medication, such as talk therapy. Clinics that integrate behavioral health providers and psychiatric consultations tend to offer more effective care, but such collaborative approaches remain uncommon. The author notes that primary care providers receive more mental health training today, but patients often prefer medication over lifestyle changes due to convenience.

Stigma has historically discouraged people from seeking mental healthcare, but access has improved since the COVID-19 pandemic. Telehealth rules introduced during the pandemic made it easier for people to receive mental health treatment, including therapy and medication, remotely. By 2022, roughly one-third of antidepressant prescriptions were issued via telehealth, up from just 1% to 2% before the pandemic. The pandemic also increased the prevalence of anxiety and depression, particularly among adolescents and young adults, especially young women. These trends have contributed to a rise in antidepressant prescriptions since 2020, as virtual visits reduce barriers like stigma and inconvenience.

While some patients may not benefit from antidepressants or could address their symptoms through other means, expanded access to mental healthcare has enabled more people in need to receive treatment. However, the author argues that systemic issues in the U.S. healthcare system play a significant role in antidepressant overprescription. Primary care clinics are well-suited for screening mental health issues, but accessing specialized care is often difficult for patients. Clinicians also receive little support in providing non-medication treatments, such as lifestyle changes, which may lead to more prescriptions. The imbalance reflects broader challenges in the healthcare system rather than just prescribing habits or patient requests.

Stopping antidepressants can be challenging for some people, as the brain and body adapt to the medication over time. This adaptation process is similar to what happens with other substances, such as caffeine. People who stop antidepressants after long-term use often experience withdrawal symptoms, which can include sleep problems, flu-like symptoms, headaches, and an electrical buzzing sensation in the head. A 2024 review found that roughly a quarter of people stopping antidepressants experienced some withdrawal symptoms, with 3% experiencing severe symptoms. While certain antidepressants are more likely to cause withdrawal, it is difficult to predict who will struggle the most. Most patients, however, can successfully discontinue these drugs with the guidance of an experienced clinician.